Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

D.Pharm To Remain Minimum Qualification To Become Pharmacist in Bihar: Patna HC

Farhat Nasim12 April 2025 4:42 PM IST

Though B.Pharm and M.Pharm are higher qualifications, the court said D.Pharm as the fixed minimum can't be questioned just for seeming unwise or...

Blacklisted Gujarat Pharma Firm's Injection Causes Memory Loss in Pregnant Women

Farhat Nasim11 April 2025 4:18 PM IST

The company was blacklisted in December 2024 for 2 years after a quality complaint. It was banned from government contracts for 5 years, and fined Rs...

Pharma Scam worth Rs 10 Cr in Ludhiana: Company Employees Booked for Massive Internal Fraud

Farhat Nasim11 April 2025 4:16 PM IST

Ludhiana: A major pharmaceutical company located in Ludhiana's Industrial Area A has become the latest victim of internal financial fraud, with losses...

Court Removes Injunction on Sun Pharma's LEQSELVI Launch in US

Farhat Nasim10 April 2025 6:05 PM IST

Delhi: In a major relief to Sun Pharmaceutical Industries Ltd, the U.S. Court of Appeals for the Federal Circuit has vacated a preliminary injunction...

No Free Pass: CDSCO Mandates Registration, Import License for SEZ Drugs Sold in India

Farhat Nasim10 April 2025 2:54 PM IST

New Delhi: The Central Drugs Standard Control Organization (CDSCO) has issued a comprehensive circular laying down regulatory procedures for...

Cardiac, GI Power Indian Pharma Market's 7.5% March Surge

Farhat Nasim9 April 2025 5:39 PM IST

New Delhi: The Indian Pharmaceutical Market (IPM) registered a healthy growth of 7.5% in value and 1.8% in unit volumes for the month of March 2025,...

Indore Doctor Loses Crores in Online Fraud

Ahmedabad-Based Troikaa Pharma Falls Victim To Rs 50 Lakh Cyber Fraud

Farhat Nasim9 April 2025 5:38 PM IST

Ahmedabad: An Ahmedabad-based pharmaceutical company has become the latest victim of a sophisticated cyber fraud involving email spoofing and forged...

Dettol Controversy: Reckitt Settles with Influencer Raj Shamani, But To Proceed Legally Against Dermatologist

Dettol vs. Dermatologist: HC Orders Influencer to Delete Disparaging Claims

Farhat Nasim8 April 2025 7:33 PM IST

New Delhi: In relief to Reckitt Benckiser (India) Limited, the Delhi High Court on Tuesday recorded an undertaking by social media influencer Raj...

Not a Nice Time For Dr Reddys? DTAB, CDSCO Recommends Stringent Restrictions on Nimesulide

Dr Reddy's Slapped Rs 2,395 Cr Income Tax Notice, Pharma Giant Denies Allegations

Farhat Nasim8 April 2025 6:07 PM IST

Hyderabad: The Income Tax Department has issued a show cause notice to Dr Reddy's Laboratories Limited, proposing a tax demand exceeding Rs 2,395...

Mankind's KIND Brand Upheld by Delhi HC, KINDPAN Trademark Quashed

Farhat Nasim7 April 2025 5:27 PM IST

New Delhi: In a major relief to Mankind Pharma Limited, the Delhi High Court has directed the removal of the trademark KINDPAN from the Register...

Roche receives CE Mark for Chest Pain Triage algorithm for Acute Coronary Syndrome

Risdiplam Price Disparity in India vs China, Pakistan: SC Issues Notice to Roche

Farhat Nasim6 April 2025 2:00 PM IST

It was submitted that why can't the Indian government negotiate with Roche to make the medicine for the rare disorder available at a cheaper rate.

India's Medical Device Exports to US Hit by 26% Reciprocal Tariff: AiMeD Raises Concerns

Farhat Nasim6 April 2025 11:15 AM IST

New Delhi: The imposition of a 26% reciprocal tariff by the United States on Indian medical device exports has raised serious concerns within the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok